AC

Ann-Marie Campbell

FT Forma Therapeutics: 5 patents #1 of 28Top 4%
BG Bayer Intellectual Property Gmbh: 1 patents #18 of 138Top 15%
📍 Monroe, CT: #4 of 43 inventorsTop 10%
🗺 Connecticut: #152 of 3,763 inventorsTop 5%
Overall (2018): #21,787 of 503,207Top 5%
6
Patents 2018

Issued Patents 2018

Showing 1–6 of 6 patents

Patent #TitleCo-InventorsDate
10005734 Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors Jian Lin, Anna Ericsson, Gary Gustafson, Zhongguo Wang, R. Bruce Diebold +4 more 2018-06-26
10000495 Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors Stephanos Ioannidis, Adam Charles Talbot, Bruce Follows, Alexandre Joseph Buckmelter, Minghua Wang 2018-06-19
RE46856 Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis Martin F. Hentemann, Jill Wood, William Scott, Martin Michels, Ann-Marie Bullion +2 more 2018-05-22
9938300 Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors Stephanos Ioannidis, Adam Charles Talbot, Bruce Follows, Alexandre Joseph Buckmelter, Minghua Wang 2018-04-10
9932351 Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors Stephanos Ioannidis, Adam Charles Talbot, Bruce Follows, Alexandre Joseph Buckmelter, Minghua Wang +1 more 2018-04-03
9902728 Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors Stephanos Ioannidis, Adam Charles Talbot, Bruce Follows, Alexandre Joseph Buckmelter, Minghua Wang +6 more 2018-02-27